Back to School: How biopharma can reboot drug development. Access exclusive analysis here

CCS/C-adjuvated influenza vaccine: Phase I/IIa started

NSVX began a double-blind, dose-escalation,

Read the full 53 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE